# Processa Pharmaceuticals, Inc.: Form 8-K, filed Jan 22, 2014

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K
- Filed: 2014-01-22
- Accepted by EDGAR: Jan 22, 2014, 10:17 ET
- Period: 2014-01-15
- Accession: 0001393905-14-000028
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000139390514000028/hwux_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000139390514000028/

## Items reported

- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000139390514000028/hwux_8k.htm

Filed Jan 22, 2014.
Source: SEC EDGAR, the filing index for accession 0001393905-14-000028. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
